Transparency and advertising: reporting benefits to INFARMED

Transparency and advertising: reporting benefits to INFARMED

PhaRegistrum · Originally published on 20/01/2026

Under Portuguese Decree-Law No. 5/2017, medicine and/or medical device manufacturers and distributors must report benefits granted to healthcare entities or professionals through INFARMED’s Transparency and Advertising Platform.

Benefits include any advantage or monetary value, such as awards, sponsorships, subsidies, fees and grants.

The deadline is 30 working days after granting the benefit.

PhaRegistrum supports the reporting process and compliance with these obligations.

#PhaRegistrum
#Transparência
#Infarmed
#Compliance
#MedicalDevices
#Medicamentos
#ConsultoriaRegulamentar

View original post on LinkedIn

Back to the publication archive